Novartis has reported that its pivotal Phase III RemIND trial, evaluating oral remibrutinib in CIndU, achieved primary endpoint.The post Novartis’...
MSD and Mayo Clinic have entered a R&D collaboration to use AI, advanced analytics, and clinical data in support of...
Portal Diabetes has received the US FDA breakthrough device designation for its implantable insulin pump system, known as the Portal...
Janux Therapeutics has dosed the first participant in a Phase I clinical trial of JANX011, a CD19-targeted bispecific candidate designed...
J&J has received the US FDA approval for a new monthly dosing schedule for the combination therapy Rybrevant Faspro to...
VB Spine is to acquire Augmedics’ xvision Spine System to add augmented reality (AR) navigation to its enhanced visualisation offerings.The...
CStone Pharmaceuticals' IND application has received FDA clearance, enabling the company to initiate a Phase II trial of its trispecific...
ExCellThera, along with its wholly owned subsidiary Cordex Biologics, has received Status 1 listing from the NUB programme in Germany...
Novartis has announced final data from the Phase III ALIGN study, highlighting that Vanrafia slowed kidney function decline in adults...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.